PubRank

Ramon Gomis

Author PubWeight™ 95.23‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial. Lancet 2002 9.48
2 Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 2009 8.54
3 Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial. JAMA 2003 8.47
4 Improvement of glycemic control in subjects with poorly controlled type 2 diabetes: comparison of two treatment algorithms using insulin glargine. Diabetes Care 2005 3.55
5 Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial. Eur Heart J 2010 2.68
6 Mitofusin 2 in POMC neurons connects ER stress with leptin resistance and energy imbalance. Cell 2013 2.43
7 Twelve- and 52-week efficacy of the dipeptidyl peptidase IV inhibitor LAF237 in metformin-treated patients with type 2 diabetes. Diabetes Care 2004 1.75
8 Identification of a pancreatic stellate cell population with properties of progenitor cells: new role for stellate cells in the pancreas. Biochem J 2009 1.64
9 GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg 2006 1.60
10 Histone demethylase LSD1 regulates adipogenesis. J Biol Chem 2010 1.50
11 [Organization and functioning model of biomedical research structures. Situation and future challenges]. Med Clin (Barc) 2008 1.46
12 Histone H3 lysine 4 dimethylation signals the transcriptional competence of the adiponectin promoter in preadipocytes. J Biol Chem 2006 1.21
13 Impairment of the ubiquitin-proteasome pathway is a downstream endoplasmic reticulum stress response induced by extracellular human islet amyloid polypeptide and contributes to pancreatic beta-cell apoptosis. Diabetes 2007 1.10
14 Induction of pancreatic islet cell differentiation by the neurogenin-neuroD cascade. Differentiation 2007 1.09
15 Short-term effects of gastric bypass surgery on circulating ghrelin levels. Obes Res 2004 1.06
16 Hypothalamic and brainstem neuronal circuits controlling homeostatic energy balance. J Endocrinol 2014 1.05
17 Circulating peptide YY, weight loss, and glucose homeostasis after gastric bypass surgery in morbidly obese subjects. Ann Surg 2008 1.04
18 Chromatin and chromatin-modifying proteins in adipogenesis. Biochem Cell Biol 2007 1.02
19 Identification of the bHLH factor Math6 as a novel component of the embryonic pancreas transcriptional network. PLoS One 2008 1.00
20 Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study). Cardiovasc Diabetol 2008 0.99
21 Deletion of miRNA processing enzyme Dicer in POMC-expressing cells leads to pituitary dysfunction, neurodegeneration and development of obesity. Mol Metab 2012 0.98
22 Insulin hypersecretion in islets from diet-induced hyperinsulinemic obese female mice is associated with several functional adaptations in individual β-cells. Endocrinology 2013 0.97
23 Insulin resistance, inflammation, and the metabolic syndrome following Roux-en-Y gastric bypass surgery in severely obese subjects. Diabetes Care 2007 0.97
24 Involvement of the clock gene Rev-erb alpha in the regulation of glucagon secretion in pancreatic alpha-cells. PLoS One 2013 0.97
25 Cyclin-dependent kinase 4 hyperactivity promotes autoreactivity in the immune system but protects pancreatic cell mass from autoimmune destruction in the nonobese diabetic mouse model. J Immunol 2008 0.94
26 Development and functional characterization of insulin-releasing human pancreatic beta cell lines produced by electrofusion. J Biol Chem 2011 0.93
27 Role of myotonic dystrophy protein kinase (DMPK) in glucose homeostasis and muscle insulin action. PLoS One 2007 0.92
28 A chromatin perspective of adipogenesis. Organogenesis 2010 0.92
29 Insulin glargine-based therapy improves glycemic control in patients with type 2 diabetes sub-optimally controlled on premixed insulin therapies. Diabetes Res Clin Pract 2007 0.90
30 Pulsatile insulin release from islets isolated from three subjects with type 2 diabetes. Diabetes 2002 0.88
31 Diabetes as a case study of chronic disease management with a personalized approach: the role of a structured feedback loop. Diabetes Res Clin Pract 2012 0.88
32 Integration of DIGE and bioinformatics analyses reveals a role of the antiobesity agent tungstate in redox and energy homeostasis pathways in brown adipose tissue. Mol Cell Proteomics 2007 0.87
33 Melatonin prevents mitochondrial dysfunction and insulin resistance in rat skeletal muscle. J Pineal Res 2014 0.85
34 In vivo diabetogenic action of CD4+ T lymphocytes requires Fas expression and is independent of IL-1 and IL-18. Eur J Immunol 2011 0.85
35 Prevalence of the metabolic syndrome in Spain using regional cutoff points for waist circumference: the di@bet.es study. Acta Diabetol 2013 0.85
36 The antidiabetic agent sodium tungstate activates glycogen synthesis through an insulin receptor-independent pathway. J Biol Chem 2003 0.84
37 Targeting type 2 diabetes: lessons from a knockout model of insulin receptor substrate 2. Can J Physiol Pharmacol 2014 0.84
38 Islet amyloid polypeptide gene promoter polymorphisms are not associated with Type 2 diabetes or with the severity of islet amyloidosis. Biochim Biophys Acta 2005 0.84
39 Characterization of the transcriptional activity of the basic helix-loop-helix (bHLH) transcription factor Atoh8. Biochim Biophys Acta 2013 0.84
40 Insulin lispro is as effective as regular insulin in optimising metabolic control and preserving beta-cell function at onset of type 1 diabetes mellitus. Diabetes Res Clin Pract 2003 0.84
41 Tungstate decreases weight gain and adiposity in obese rats through increased thermogenesis and lipid oxidation. Endocrinology 2005 0.84
42 Incidence and prevalence of unrecognized myocardial infarction in people with diabetes: a substudy of the Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycemia in Diabetes (RECORD) study. Diabetes Care 2011 0.83
43 BACE2 plays a role in the insulin receptor trafficking in pancreatic ß-cells. Am J Physiol Endocrinol Metab 2010 0.83
44 Molecular mechanisms of tungstate-induced pancreatic plasticity: a transcriptomics approach. BMC Genomics 2009 0.83
45 In vivo JNK activation in pancreatic β-cells leads to glucose intolerance caused by insulin resistance in pancreas. Diabetes 2013 0.83
46 Intra-abdominal fat adiponectin receptors expression and cardiovascular metabolic risk factors in obesity and diabetes. Obes Surg 2006 0.83
47 Expression of TMEM16A and SLC4A4 in human pancreatic islets. Cell Physiol Biochem 2012 0.82
48 The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study. Diabetes Technol Ther 2014 0.82
49 Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: Fc construct. Eur J Immunol 2003 0.81
50 Sequence and epigenetic determinants in the regulation of the Math6 gene by Neurogenin3. Differentiation 2011 0.80
51 Role of IGFBP-3 in the regulation of β-cell mass during obesity: adipose tissue/β-cell cross talk. Endocrinology 2011 0.80
52 Ambient temperature and prevalence of obesity in the Spanish population: The Di@bet.es study. Obesity (Silver Spring) 2014 0.80
53 Application of electrophoretic mobility shift assay and chromatin immunoprecipitation in the study of transcription in adipose cells. Methods Mol Biol 2008 0.80
54 Phosphorylation events implicating p38 and PI3K mediate tungstate-effects in MIN6 beta cells. Biochem Biophys Res Commun 2007 0.80
55 Inhibition of GSK3 dependent tau phosphorylation by metals. Curr Alzheimer Res 2006 0.79
56 S 23521 decreases food intake and body weight gain in diet-induced obese rats. Obes Res 2004 0.79
57 Sodium tungstate decreases the phosphorylation of tau through GSK3 inactivation. J Neurosci Res 2006 0.79
58 Amylin and hypertension: association of an amylin -G132A gene mutation and hypertension in humans and amylin-induced endothelium dysfunction in rats. J Clin Endocrinol Metab 2007 0.79
59 Impaired glucose tolerance: is there a case for pharmacologic intervention? Treat Endocrinol 2002 0.79
60 Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 activity exerts an antidiabetic action in Goto-Kakizaki rats. Diabetes 2003 0.78
61 Downregulation of Sfrp5 promotes beta cell proliferation during obesity in the rat. Diabetologia 2013 0.78
62 Histone demethylase KDM1A represses inflammatory gene expression in preadipocytes. Obesity (Silver Spring) 2013 0.78
63 Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats. Proteomics 2005 0.78
64 Adult-onset atypical (type 1) diabetes: additional insights and differences with type 1A diabetes in a European Mediterranean population. Diabetes Care 2004 0.78
65 Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls. Diabetes Metab Res Rev 2014 0.77
66 A functional leptin system is essential for sodium tungstate antiobesity action. Endocrinology 2008 0.77
67 Anti-obesity sodium tungstate treatment triggers axonal and glial plasticity in hypothalamic feeding centers. PLoS One 2012 0.77
68 Integrative analysis reveals novel pathways mediating the interaction between adipose tissue and pancreatic islets in obesity in rats. Diabetologia 2014 0.77
69 The sole presence of CDK4 is not a solid criterion for discriminating between tumor and healthy pancreatic tissues. Int J Cancer 2011 0.76
70 Transcript expression of two Iglambda rearrangements and RAG-1/RAG-2 in a mature human B cell producing IgMlambda islet cell autoantibody. J Clin Immunol 2003 0.76
71 Tungstate promotes β-cell survival in Irs2-/- mice. Am J Physiol Endocrinol Metab 2013 0.76
72 Gastric inhibitory polypeptide receptor methylation in newly diagnosed, drug-naïve patients with type 2 diabetes: a case-control study. PLoS One 2013 0.76
73 Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design. Diabetes Metab Syndr Obes 2009 0.75
74 Site-directed mutations in the FAD-binding domain of glycerophosphate dehydrogenase: catalytic defects with preserved mitochondrial anchoring of the enzyme in transfected COS-7 cells. Mol Genet Metab 2002 0.75
75 True anti-anionic phospholipid immunoglobulin M antibodies can exert lupus anticoagulant activity. Br J Haematol 2002 0.75
76 [Scientific and technical advances in biomedicine: reflection on clinical management]. Med Clin (Barc) 2008 0.75